Skip to main content Help with accessibility Skip to main navigation

July 2021 updates to the website

The website has now been updated following July's LSCMMG

The following guidelines have been added/updated:

Trans female gender dysphoria information sheet - Updated 

The following medicines have been added/updated:

Budesonide orodispersible tablet (NICE TA708) - For inducing remission of eosinophilic oesophagitis

Guselkumab (NICE TA711) - For treating active psoriatic arthritis after inadequate response to DMARDs

The following Items will be updated and added to the website following the next Strategic Commissioning Committee (SCC) Meeting:

Sodium oxybate - Narcolepsy with cataplexy

Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (Sativex®) - For symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication